| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00024 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.00019 | 1 |